Tumor Immunology & Immunotherapy

We are pleased to announce the Cold Spring Harbor Asia conference on Tumor Immunology & Immunotherapy which will be held in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Sunday October 22, and will conclude after lunch on October 26 (Thursday), 2017.

The conference will include eight oral sessions and one poster session covering the latest findings across many topics in cancer biology. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

Major Topics: 
1. Defining tumor antigens and immunogenicity
2. Immune checkpoint blockade and antibody therapy
3. Adoptive T cell therapy
4. Vaccine-based immunotherapy
5. Gut microbiota, immunity and cancer
6. Inflammation, tumor microenvironment and immune escape
7. New approach to cancer immunotherapy

Keynote Speakers:
Robert Schreiber, Washington University, School of Medicine, USA
Laurence Zitvogel, Institut Gustave Roussy(IGR), FRANCE 
Invited Speakers:
Jay Berzofsky, National Cancer Institute, NIH, USA
Abstract title: Cancer vaccines and immunotherapy: translation from mice to human clinical trials 
Renier Brentjens, Memorial Sloan Kettering Cancer Center, USA
Xuetao Cao, Chinese Academy of Medical Sciences/The Second Military Medical University, CHINA
Vincenzo Cerundolo, University of Oxford, UNITED KINGDOM
Abstract title: Amino acid degrading enzymes and their role in tumour immune escape mechanisms 
Adelheid Cerwenka, German Cancer Research Center, GERMANY
Phillip Darcy, Peter MacCallum Cancer Institute, AUSTRALIA
Olivera Finn, University of Pittsburgh School of Medicine, USA
Yang-Xin Fu, UT Southwestern Medical Center, USA
Abstract title: Targeting tumor cells to trigger immunity 
Dmitry Gabrilovich, The Wistar Institute, USA
Guido Kroemer, Institute Gustav Roussy, FRANCE
Alberto Mantovani, Humanitas Clinical and Research Center, ITALY
Abstract title: The yin-yang of innate immunity, inflammation and cancer 
Augusto Ochoa, Louisiana State University Health Sciences Center, USA
Pamela Ohashi, Princess Margaret Hospital, CANADA
Suzanne Ostrand-Rosenberg, University of Maryland, USA
Abstract title: Myeloid-derived suppressor cells (MDSC): Their ying and yang effects in tumor-bearing obese mice 
Bruce Robinson, The University of Western Australia, AUSTRALIA
Abstract title: Augmenting and broadening T-cell responses against mutated tumor neo-antigens 
Pramod Srivastava, University of Connecticut Health School of Medicine, USA
Zhigang Tian, University of Science & Technology of China, CHINA
Abstract title: TIGIT blockade prevents NK cell exhaustion and elicits potent anti-tumor immunity 
Dario Vignali, University of Pittsburgh, USA
Weiping Zou, University of Michigan Medical School, USA

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers. 

Fellowship: 
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards. For more details, please visit http://www.csh-asia.org/stipends.html

We look forward to seeing you at Suzhou in October, 2017.